EcoDrugPlus

Solute Carrier Family 6 Member 4

Ensembl ID : ENSLBEG00000019114
Gene Symbol: SLC6A4
3 Cross references
201 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSLBEG00000016187
Gene Symbol: SLC9A3
4 Cross references
232 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSLBEG00000001093
Gene Symbol: SLC9A3
3 Cross references
232 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSLBEG00000018813
Gene Symbol: SSTR1
1 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSLBEG00000023719
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSLBEG00000000545
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSLBEG00000011892
Gene Symbol: SSTR3
2 Cross references
183 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSLBEG00000005251
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Sphingosine 1-Phosphate Receptor 1-Like

Ensembl ID : ENSLBEG00000028949
Gene Symbol: LOC109979748
3 Cross references
198 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSLBEG00000024525
Gene Symbol: SYK
1 Cross references
199 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSLBEG00000015788
Gene Symbol: SYK
1 Cross references
199 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSLBEG00000005022
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).